Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review
| Image |  |
|---|---|
| Description | scientific article |
| Author/s | |
| Publication date | May 17, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |